The Singapore Bioimaging Consortium (SBIC) aims to build a coordinated national programme for imaging research, bringing together substantial strengths in the physical sciences and engineering and those in the biomedical sciences. SBIC seeks to identify and consolidate the various bioimaging capabilities across local research institutes, universities and hospitals in order to speed the development of biomedical research discoveries.
SBIC's intramural programme comprises eight research units, namely the Magnetic Resonance Imaging Group (MRIG), Translational Molecular Imaging Group (TMIG), Magnetic Resonance Spectroscopy/Molecular Imaging (MRS/MI) Group, PET and SPECT Development Group, Bio-optical Imaging Group (BOIG), Lab of Metabolic Medicine (LMM), Lab of Bioimaging Probe Development (LBPD) and Biomedical Imaging Lab (BIL) More >>
* Note: MRIG, TMIG, MRS/MI Group, PET and SPECT Development Group, and BOIG are collectively called the Lab of Molecular Imaging (LMI).
RESEARCH AREAS
SBIC has an Integrated Research Programme among LMI, LMM, and LBPD
- Molecular Regulation of Hormone Secretion and Signaling
- Glucose/Lipid Metabolism and Metabolic Syndrome
- Metabolic Syndromes and Neurodegeneration
- Clinical Translation of Probe Development and Imaging Technologies
Other research areas
- Development of MR Imaging Technologies for non-invasive cellular and molecular detection
- Leptin signaling pathways in neurons
- Processing, analysis, modeling, and visualisation of biomedical images
- Construction of human brain atlases
- Development of atlas-assisted solutions for neurological disorders
- Quantitative Magnetic Resonance Spectroscopic approaches for investigation of tissue biochemistry in vivo
- In vivo investigation of lipid and energy metabolism in Liver and Skeletal Muscle
- Detection of new biomarkers by Magnetic Resonance Spectroscopy for designing therapeutic interventions in diabetes, Cancer and neurodegeneration
- In vivo Detection of Glucose, GABA, Glutathione, Glutamate, Glutamine in the brain
- Development of novel multimodal contrast agents for cellular function/tracking
- In vivo cell tracking using non-invasive imaging in pre-clinical models
- Assessment of stem cell therapy using non-invasive imaging
- Development of quantitative imaging techniques using microPET and microSPECT
- Detector development for combined MR/microPET imaging
- Techniques for cross modality imaging of PET, SPECT and MR
|
